전체 논문 (58편 · 1/2)
-
RUVBL1-mediated mTORC1 activation drives tumour progression and immune evasion for oral squamous cell carcinoma.
-
LAG-3 at the crossroads: A context-dependent regulator of Tregs and autoimmunity inflammatory disorders.
-
FLVCR2: structure, substrate transport, and emerging roles in human disease.
-
Adiponectin receptor agonist, AdipoRon, reduces the growth of prostate cancer cells and patient-derived organoids.
-
Cabozantinib induces NLRP3-CASP1-GSDMD-dependent pyroptosis in hepatocellular carcinoma.
-
Emodin induces oxidative stress and Ferroptosis in hepatocellular carcinoma cells through the miR-4465/NFE2L3/HMGCR/GPX4 signaling axis.
-
Retraction notice to "In-vitro and in-vivo investigation of amygdalin, metformin, and combination of both against doxorubicin on hepatocellular carcinoma" [Life Sciences 285 (2021) 119961].
-
Endostar overcomes Osimertinib-resistance mediated EGFR-activation mutation, T790M and cis-C797S triple mutations via enhancing the binding of Osimertinib to EGFR protein.
-
Multidrug resistant non-small cell lung cancer cells exhibiting collateral sensitivity to DNA damaging drugs.
-
Membrane protein-focused CRISPR screen identifies ATP2A2 as a druggable transcriptional co-regulator of CCND1 (cyclin D1) in lung adenocarcinoma.
-
CRISPR's impact on cancer: From fundamental models to clinical solutions.
-
Epithelial-mesenchymal transition and tumor-associated macrophage axis in metastatic breast cancer: converging mechanisms and therapeutic perspectives.
-
The role of tumor microenvironment in regulating tumor cell dormancy.
-
The roles of extrachromosomal DNA in tumorigenesis and therapeutic resistance in cancer.
-
Ezrin (EZR) promotes breast cancer progression and drug resistance: Molecular mechanisms involving STAT3 activation.
-
Nucleophagy: The guardian of genome stability - from molecular mechanisms to disease associations.
-
Schwann cells as immunomodulators in the tumor immune microenvironment: Mechanisms and therapeutic implications.
-
Actin-regulated plasticity as a key determinant of the bidirectional switch between chemoresistance and resensitization in triple-positive breast cancer.
-
Decoding the mitochondrial metabolic engine for tumor metastasis and clinical therapeutic opportunities.
-
MAPK1 phosphorylates CCNB1 at Ser128 to drive mitotic progression and cell proliferation in triple-negative breast cancer.
-
Retraction notice to "Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice" [Life Sci. 266 (2021) 118847].
-
PPP3CB inhibits pancreatic cancer progression by promoting ATOH8 translocation and transcriptionally regulating Sp1.
-
PLIN5 affects the fibrosis and progression of pancreatic cancer via modulation of pancreatic stellate cells.
-
N6-methyladenosine-modified circQKI inhibits prostate cancer docetaxel-sensitivity via miR-188-3p/Beclin-1 pathway.
-
Chronic administration of the hydrogen sulfide prodrug SG1002 partially protects against erectile dysfunction resulting from long-term androgen deprivation.
-
MCP-enhanced SOD3 activity inhibits gastric cancer and potentiate chemotherapy via modulating EGFR signaling.
-
MZT1 protects gastric cancer against glucose starvation through targeting NEDD1.
-
TRAF1 promotes the progression of Helicobacter pylori-associated gastric cancer through EGFR/STAT/OAS signalling.
-
Gastric dilation following vertical sleeve gastrectomy reflects adaptive stem cell-driven regeneration without association with weight regain or increased cancer risk.
-
Exploring the double-edged role of cellular senescence in chronic liver disease for new treatment approaches.